cIAP-2/HIAP-1 Antibody (OTI1A9) [DyLight 488]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-70184G
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry, Western Blot
Label
DyLight 488 (Excitation = 493 nm, Emission = 518 nm)
Antibody Source
Monoclonal Mouse IgG1 Clone # OTI1A9
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Recombinant protein fragment corresponding to amino acids 255-529 of human cIAP-2/HIAP-1 (NP_001156) produced in E.coli.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for cIAP-2/HIAP-1 Antibody (OTI1A9) [DyLight 488]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: cIAP-2/HIAP-1
Alternate Names
BIRC3, cIAP2, HIAP-1, MIHC
Gene Symbol
BIRC3
Additional cIAP-2/HIAP-1 Products
Product Documents for cIAP-2/HIAP-1 Antibody (OTI1A9) [DyLight 488]
Product Specific Notices for cIAP-2/HIAP-1 Antibody (OTI1A9) [DyLight 488]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...